FDA’s Top Agenda Maker: Commissioner, Congress – Or The Courts?
This article was originally published in The Tan Sheet
Executive Summary
Agency chief counsel says continued priority-setting through lawsuits eventually may affect public health, while professor says FDA discretion not to act is at stake in some cases.